$BCBP
BCB BANCORP INC

2023 Q3 Form 10-Q Financial Statement

#000122845423000011 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $49.07M $47.24M
YoY Change 42.64% 55.07%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $500.0K $486.0K
YoY Change 1.42% -24.3%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $23.39M $20.25M
YoY Change 578.08% 644.41%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $9.418M $12.05M
YoY Change -50.29% -16.15%
Income Tax $2.707M $3.447M
% Of Pretax Income 28.74% 28.6%
Net Earnings $6.711M $8.430M
YoY Change -49.89% -17.05%
Net Earnings / Revenue 13.68% 17.85%
Basic Earnings Per Share $0.39 $0.50
Diluted Earnings Per Share $0.39 $0.50
COMMON SHARES
Basic Shares Outstanding 16.79M 16.84M
Diluted Shares Outstanding 16.85M 16.83M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $251.9M $273.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $13.36M $27.22M
YoY Change -40.63% 145.77%
Goodwill $5.200M $5.200M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $8.272M $12.83M
YoY Change -55.06% -32.39%
Other Assets $16.70M $16.45M
YoY Change 5.28% 21.07%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.812B $3.873B
YoY Change 16.74% 26.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $13.30M $14.00M
YoY Change 9.9% 12.06%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.30M $14.00M
YoY Change 9.9% 12.06%
LONG-TERM LIABILITIES
Long-Term Debt $37.60M $37.62M
YoY Change 0.4% 0.62%
Other Long-Term Liabilities $15.30M $13.35M
YoY Change 84.14% 44.58%
Total Long-Term Liabilities $52.90M $50.97M
YoY Change 15.61% 9.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.30M $14.00M
Total Long-Term Liabilities $52.90M $50.97M
Total Liabilities $3.508B $3.573B
YoY Change 17.62% 27.56%
SHAREHOLDERS EQUITY
Retained Earnings $132.7M $128.9M
YoY Change 25.34% 35.09%
Common Stock $198.1M $197.5M
YoY Change 1.56% 1.52%
Preferred Stock $20.78M $21.00M
YoY Change -1.05% 26.81%
Treasury Stock (at cost) $38.35M $38.35M
YoY Change 15.77% 20.25%
Treasury Stock Shares
Shareholders Equity $303.6M $299.6M
YoY Change
Total Liabilities & Shareholders Equity $3.812B $3.873B
YoY Change 16.74% 26.04%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $6.711M $8.430M
YoY Change -49.89% -17.05%
Depreciation, Depletion And Amortization $500.0K $486.0K
YoY Change 1.42% -24.3%
Cash From Operating Activities $10.00M $8.109M
YoY Change -23.18% 2.08%
INVESTING ACTIVITIES
Capital Expenditures $300.0K $3.941M
YoY Change -314.29% -4965.43%
Acquisitions
YoY Change
Other Investing Activities $37.90M -$96.64M
YoY Change -120.88% -56.89%
Cash From Investing Activities $37.60M -$100.6M
YoY Change -120.7% -55.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -68.80M 104.6M
YoY Change -137.5% 306.09%
NET CHANGE
Cash From Operating Activities 10.00M 8.109M
Cash From Investing Activities 37.60M -100.6M
Cash From Financing Activities -68.80M 104.6M
Net Change In Cash -21.20M 12.14M
YoY Change -242.74% -106.37%
FREE CASH FLOW
Cash From Operating Activities $10.00M $8.109M
Capital Expenditures $300.0K $3.941M
Free Cash Flow $9.700M $4.168M
YoY Change -26.27% -48.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Expired Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExpiredExercisePriceRange
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRange
bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRange
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity Central Index Key
EntityCentralIndexKey
0001228454
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-50275
dei Entity Registrant Name
EntityRegistrantName
BCB Bancorp, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
823-0700
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
BCBP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16788483
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
13378000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11520000
CY2023Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
259834000
CY2023Q2 us-gaap Subordinated Debt
SubordinatedDebt
37624000
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
37508000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
14003000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13859000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
13346000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
9704000
CY2023Q2 us-gaap Liabilities
Liabilities
3573230000
CY2022Q4 us-gaap Liabilities
Liabilities
3254939000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
217839000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273212000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2023Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87648000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91715000
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
12825000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17686000
CY2022Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
658000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
30205000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
32373000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3319721000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3045331000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
31667000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
20113000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13561000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10508000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
15384000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
13455000
CY2023Q2 us-gaap Other Real Estate
OtherRealEstate
75000
CY2022Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16445000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16462000
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5324000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5382000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13658000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13520000
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
72344000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
71656000
CY2023Q2 us-gaap Other Assets
OtherAssets
10254000
CY2022Q4 us-gaap Other Assets
OtherAssets
9538000
CY2023Q2 us-gaap Assets
Assets
3872853000
CY2022Q4 us-gaap Assets
Assets
3546193000
CY2023Q2 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
620509000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
613910000
CY2023Q2 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2265212000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2197697000
CY2023Q2 us-gaap Deposits
Deposits
2885721000
CY2022Q4 us-gaap Deposits
Deposits
2811607000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
622536000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
382261000
us-gaap Interest Income Other
InterestIncomeOther
2190000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2123
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2123
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2123
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2123
CY2023Q2 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
21003000
CY2022Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
21003000
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20022454
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19898197
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16788483
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16930979
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
197521000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
196164000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
128867000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
115109000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9421000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6491000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3233971
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2967218
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
38347000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34531000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
299623000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
291254000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3872853000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3546193000
CY2023Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
42644000
CY2022Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
28781000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
81533000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
55102000
CY2023Q2 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
184000
CY2022Q2 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
47000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
370000
us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
206000
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
1070000
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
939000
us-gaap Interest Income Other
InterestIncomeOther
1887000
CY2023Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
3339000
CY2022Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
694000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
5496000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
990000
CY2023Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
47237000
CY2022Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
30461000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
89589000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
58185000
CY2023Q2 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
4190000
CY2022Q2 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
946000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
7344000
us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
1704000
CY2023Q2 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
143000
CY2022Q2 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
110000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
261000
us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
218000
CY2023Q2 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
8474000
CY2022Q2 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
849000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
14927000
us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1829000
CY2023Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
12807000
CY2022Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1905000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
22532000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
3751000
CY2023Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
7441000
CY2022Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
815000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
12597000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1621000
CY2023Q2 us-gaap Interest Expense
InterestExpense
20248000
CY2022Q2 us-gaap Interest Expense
InterestExpense
2720000
us-gaap Interest Expense
InterestExpense
35129000
us-gaap Interest Expense
InterestExpense
5372000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
26989000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
27741000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
54460000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52813000
CY2023Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1350000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1972000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
CY2023Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
25639000
CY2022Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
27741000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
52488000
bcbp Regulatory Assessments
RegulatoryAssessments
548000
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
350000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
55388000
CY2023Q2 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1442000
CY2022Q2 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1213000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2540000
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2427000
CY2023Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
267000
CY2022Q2 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
686000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
688000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1441000
CY2022Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
43000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
6000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
108000
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-669000
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2302000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3896000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4987000
CY2023Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
78000
CY2022Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
47000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
116000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
98000
CY2023Q2 us-gaap Noninterest Income
NoninterestIncome
1118000
CY2022Q2 us-gaap Noninterest Income
NoninterestIncome
-313000
us-gaap Noninterest Income
NoninterestIncome
-546000
us-gaap Noninterest Income
NoninterestIncome
-913000
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7711000
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6715000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
15329000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
13451000
CY2023Q2 us-gaap Occupancy Net
OccupancyNet
2560000
CY2022Q2 us-gaap Occupancy Net
OccupancyNet
2673000
us-gaap Occupancy Net
OccupancyNet
5112000
us-gaap Occupancy Net
OccupancyNet
5368000
CY2023Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1795000
CY2022Q2 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1469000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3460000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2934000
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
622000
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
489000
us-gaap Professional Fees
ProfessionalFees
1188000
us-gaap Professional Fees
ProfessionalFees
983000
CY2023Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
270000
CY2022Q2 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
296000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
535000
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
617000
CY2023Q2 bcbp Regulatory Assessments
RegulatoryAssessments
796000
CY2022Q2 bcbp Regulatory Assessments
RegulatoryAssessments
244000
bcbp Regulatory Assessments
RegulatoryAssessments
1332000
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
254000
us-gaap Advertising Expense
AdvertisingExpense
628000
us-gaap Advertising Expense
AdvertisingExpense
395000
CY2023Q2 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
1000
CY2022Q2 bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
4000
bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
2000
bcbp Other Real Estate Owned Net
OtherRealEstateOwnedNet
5000
CY2023Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
601000
CY2022Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
912000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
974000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1714000
CY2023Q2 us-gaap Noninterest Expense
NoninterestExpense
14706000
CY2022Q2 us-gaap Noninterest Expense
NoninterestExpense
13056000
us-gaap Noninterest Expense
NoninterestExpense
28560000
us-gaap Noninterest Expense
NoninterestExpense
26015000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12051000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14372000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23382000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28460000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3447000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4209000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6672000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8345000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8604000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
10163000
us-gaap Net Income Loss
NetIncomeLoss
16710000
us-gaap Net Income Loss
NetIncomeLoss
20115000
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
174000
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
138000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
347000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
414000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8430000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10025000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16363000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19701000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16824000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111000
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
115000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16997000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16886000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16989000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16831000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17404000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17010000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17375000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8604000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
10163000
us-gaap Net Income Loss
NetIncomeLoss
16710000
us-gaap Net Income Loss
NetIncomeLoss
20115000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3803000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-2290000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3790000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-5485000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-995000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-568000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-860000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1360000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2808000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1722000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2930000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4125000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5796000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8441000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13780000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15990000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
291254000
us-gaap Net Income Loss
NetIncomeLoss
16710000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2930000
bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
61000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
418000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
217000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
266753
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3816000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
347000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5280000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
527000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
299623000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
297618000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8604000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2808000
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1257000
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
174000
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2593000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
122000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
299623000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
us-gaap Net Income Loss
NetIncomeLoss
20115000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4125000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
191000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
43113
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
764000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
450000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
14730000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2370000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5213000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
219000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
276159000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
10163000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1722000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
96000
CY2022Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
44598
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
756000
CY2022Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
174000
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
9650000
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2612000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
133000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
271637000
us-gaap Net Income Loss
NetIncomeLoss
16710000
us-gaap Net Income Loss
NetIncomeLoss
20115000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
964000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1242000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-1080000
bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
-522000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1972000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
877000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
736000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
4856000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
664000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
5911000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
6000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
108000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3896000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4987000
us-gaap Share Based Compensation
ShareBasedCompensation
217000
us-gaap Share Based Compensation
ShareBasedCompensation
191000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
688000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1441000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1929000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1132000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
716000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1671000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2747000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-46000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
895000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1087000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24523000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19744000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
5579000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
8118000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5453000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
15488000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
965000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1232000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
271806000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
311845000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
3500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4017000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
11554000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
697000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-286286000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-315261000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
74114000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
93628000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
250000000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
15000000
bcbp Increase Decrease In Federal Home Loan Bank Of New York Short Term Advances Net
IncreaseDecreaseInFederalHomeLoanBankOfNewYorkShortTermAdvancesNet
-10000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3816000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
764000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5280000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5213000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
347000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
450000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
527000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
219000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2370000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
14730000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
418000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
305616000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
90060000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
43853000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-205457000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273212000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206172000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8522000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9948000
us-gaap Interest Paid Net
InterestPaidNet
32382000
us-gaap Interest Paid Net
InterestPaidNet
5419000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Reclassifications
Reclassifications
<span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 3 – Reclassification </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain amounts have been reclassified to conform to the current period’s presentation. These changes had no effect on the Company’s results of operations or financial position.</span></p>
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
48150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.83
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
27000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13650
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.60
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
61500
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.27
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26700
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
33000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
6750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.89
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
52950
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.83
us-gaap Restricted Stock Expense
RestrictedStockExpense
151000
us-gaap Restricted Stock Expense
RestrictedStockExpense
54000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
813000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y11M4D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1036975
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.03
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.72
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.03
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.03
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
975975
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.55
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.89
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
65000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
88000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8430000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16824000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10025000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16997000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
407000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8430000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16831000
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10025000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17404000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16886000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19701000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16989000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
124000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
386000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17010000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19701000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17375000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-494000
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2302000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-3721000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4928000
CY2023Q2 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-175000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-175000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-59000
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-669000
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2302000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3896000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4987000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99326000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11678000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87648000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99602000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7887000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91715000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
36457000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
3382000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
49891000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
8296000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
86348000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
11678000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
72960000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5227000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
17456000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2660000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
90416000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
7887000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3354921000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3082418000
CY2023Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
4995000
CY2022Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
4714000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
30205000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
32373000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3319721000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3045331000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
39000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
12000
CY2023Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1350000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30205000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2772000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
27433000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30205000
CY2023Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
28249000
CY2023Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3326672000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3354921000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
40000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
65000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1972000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30205000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33980000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
6000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
139000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
6333000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
27780000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2022Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
42411000
CY2022Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2615471000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2657882000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
772000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
341000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-2575000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
34113000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2784000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29589000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
28272000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3054146000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
3082418000
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
689000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-435000
us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-1012000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
254000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
254000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
3354921000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3082418000
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5696000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5109000
us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
822000
CY2022 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1000000.0
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2023Q2 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
238696000
CY2023Q2 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
979093000
CY2023Q2 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
335175000
CY2023Q2 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
285785000
CY2023Q2 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
74601000
CY2023Q2 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
1079417000
CY2023Q2 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
361441000
CY2023Q2 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
713000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
3354921000
bcbp Financing Receivable Originated Five Or More Years Before Latest Fiscal Year.Charge Offs
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear.ChargeOffs
40000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
40000
CY2022Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
966179000
CY2022Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
341920000
CY2022Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
292806000
CY2022Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
78669000
CY2022Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
376336000
CY2022Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
758958000
CY2022Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
266825000
CY2022Q4 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
725000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3082418000
CY2023Q2 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
72300000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2023Q2 us-gaap Goodwill
Goodwill
5200000
CY2022Q2 us-gaap Goodwill
Goodwill
5200000
CY2022Q4 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2023Q2 bcbp Transfers Between Fair Value Hierarchies Assets Liabilities
TransfersBetweenFairValueHierarchiesAssetsLiabilities
0
CY2023Q2 us-gaap Other Real Estate
OtherRealEstate
75000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
116000
bcbp Lessee Operating Leases Number
LesseeOperatingLeasesNumber
25
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
896000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
938000
us-gaap Operating Lease Cost
OperatingLeaseCost
1832000
us-gaap Operating Lease Cost
OperatingLeaseCost
1840000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
256000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
257000
us-gaap Variable Lease Cost
VariableLeaseCost
524000
us-gaap Variable Lease Cost
VariableLeaseCost
476000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13658000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13520000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1631000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3062000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13797000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12218000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1425000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1421000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
14003000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13859000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M26D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0294
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0283
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1631000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3062000
CY2023Q2 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
5468000
CY2022Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4766000
CY2023Q2 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
4341000
CY2022Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3496000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3988000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3956000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15428000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15280000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1425000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1421000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
14003000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13859000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001228454-23-000011-index-headers.html Edgar Link pending
0001228454-23-000011-index.html Edgar Link pending
0001228454-23-000011.txt Edgar Link pending
0001228454-23-000011-xbrl.zip Edgar Link pending
bcbp-20230630.xsd Edgar Link pending
bcbp-20230630x10q.htm Edgar Link pending
bcbp-20230630xex31_1.htm Edgar Link pending
bcbp-20230630xex31_2.htm Edgar Link pending
bcbp-20230630xex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
bcbp-20230630_def.xml Edgar Link unprocessable
bcbp-20230630_lab.xml Edgar Link unprocessable
bcbp-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bcbp-20230630x10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bcbp-20230630_cal.xml Edgar Link unprocessable